Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05497999 · ClinicalTrials.gov registry record · NA
Racial Inequality in Inhaler Fills for COPD - A Trial of Reduced Cost-Sharing
A NA study, sponsored by Harvard Medical School (HMS and HSDM).
- Completed
- Registry status
- NA
- Development phase
- 19,113
- Enrollment target
NCT05497999 is a NA study that has completed, run by Harvard Medical School (HMS and HSDM). The registered enrollment target is 19,113 participants.
The verdict
NCT05497999, a NA study, has completed, sponsored by Harvard Medical School (HMS and HSDM).
- COMPLETED
- Registry status
- NA
- Development phase
- 19,113 participants
- Enrollment target
Study Summary
In partnership with a large Medicare Advantage (MA) insurer (Humana, Inc.) and as part of a Center for Medicare and Medicaid Innovation demonstration program of Value-Based Insurance Design (VBID), the investigators propose to study a randomized controlled quality improvement trial in which Humana randomized MA beneficiaries with COPD to receive proactive outreach for a VBID benefit that provided large reductions in cost-sharing for their maintenance inhalers and telephone-based COPD medication management services in 2020 and 2021. The investigators will analyze changes in racial disparities for inhaler fills, clinical outcomes, health care spending, and acute care utilization.
Interventions
- OTHER Proactive Outreach
- OTHER No Proactive Outreach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19,113 participants |
| Start Date | 2020-01-07 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05497999
The ClinicalTrials.gov registry entry for NCT05497999 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19,113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard Medical School (HMS and HSDM), which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Proactive Outreach is the first listed.
NCT05497999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05497999 about?
NCT05497999 is a clinical study titled "Racial Inequality in Inhaler Fills for COPD - A Trial of Reduced Cost-Sharing". In partnership with a large Medicare Advantage (MA) insurer (Humana, Inc.) and as part of a Center for Medicare and Medicaid Innovation demonstration program of Value-Based Insurance Design (VBID), the investigators propose to study a randomized controlled quality improvement trial in which Humana r...
What is the current status of trial NCT05497999?
This trial is currently completed. It is a NA study. The enrollment target is 19,113 participants. The study started on 2020-01-07. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT05497999?
The interventions under investigation include: Proactive Outreach (OTHER), No Proactive Outreach (OTHER).
Who is sponsoring clinical trial NCT05497999?
This trial is sponsored by Harvard Medical School (HMS and HSDM), which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.